Cutaneous symptoms of dermatomyositis significantly impact patients’ quality of life - 09/08/11
Winston-Salem, North Carolina
Abstract |
Background |
Dermatomyositis affects visible skin and causes disease symptoms that can affect patients’ quality of life (QOL).
Methods |
In all, 71 patients with dermatomyositis or dermatomyositis sine myositis completed two QOL measures (the Skindex-16 and the Dermatology Life Quality Index) and a visual analog scale for pruritus. Disease severity was assessed by Physician’s Global Assessment.
Results |
The mean Dermatology Life Quality Index score was 10.7 and the mean Skindex-16 score was 51.1. Itching contributed to impact on both the Dermatology Life Quality Index and Skindex-16. Females reported worse QOL.
Limitations |
The effect of treatment on quality of life was not assessed in these analyses.
Conclusion |
QOL impairment in dermatomyositis is greater than in other skin conditions including psoriasis and atopic dermatitis. Pruritus is an important treatable factor that significantly impacts QOL for patients with dermatomyositis.
Le texte complet de cet article est disponible en PDF.Abbreviations used : DLQI, PGA, QOL
Plan
Supported by National Institutes of Arthritis, Musculoskeletal and Skin Diseases grant number AR0348990-02. Conflicts of interest: None identified. |
Vol 54 - N° 2
P. 217-220 - février 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?